These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19458052)

  • 1. Inhibition of ovarian cancer growth by a tumor-targeting peptide that binds eukaryotic translation initiation factor 4E.
    Ko SY; Guo H; Barengo N; Naora H
    Clin Cancer Res; 2009 Jul; 15(13):4336-47. PubMed ID: 19458052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue targeting in cancer: eIF4E's tale.
    Borden KL
    Clin Cancer Res; 2009 Jul; 15(13):4254-5. PubMed ID: 19509132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilizing the eIF4G1 α-helix increases its binding affinity with eIF4E: implications for peptidomimetic design strategies.
    Brown CJ; Lim JJ; Leonard T; Lim HC; Chia CS; Verma CS; Lane DP
    J Mol Biol; 2011 Jan; 405(3):736-53. PubMed ID: 21094167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of bromophenol-thiazolylhydrazone hybrids inhibiting the interaction of translation initiation factors eIF4E/eIF4G as multifunctional agents for cancer treatment.
    Wang L; Guo C; Li X; Yu X; Li X; Xu K; Jiang B; Jia X; Li C; Shi D
    Eur J Med Chem; 2019 Sep; 177():153-170. PubMed ID: 31132531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.
    Konicek BW; Stephens JR; McNulty AM; Robichaud N; Peery RB; Dumstorf CA; Dowless MS; Iversen PW; Parsons S; Ellis KE; McCann DJ; Pelletier J; Furic L; Yingling JM; Stancato LF; Sonenberg N; Graff JR
    Cancer Res; 2011 Mar; 71(5):1849-57. PubMed ID: 21233335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.
    Niedzwiecka A; Marcotrigiano J; Stepinski J; Jankowska-Anyszka M; Wyslouch-Cieszynska A; Dadlez M; Gingras AC; Mak P; Darzynkiewicz E; Sonenberg N; Burley SK; Stolarski R
    J Mol Biol; 2002 Jun; 319(3):615-35. PubMed ID: 12054859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutant of eukaryotic protein synthesis initiation factor eIF4E(K119A) has an increased binding affinity for both m7G cap analogues and eIF4G peptides.
    Friedland DE; Wooten WN; LaVoy JE; Hagedorn CH; Goss DJ
    Biochemistry; 2005 Mar; 44(11):4546-50. PubMed ID: 15766285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consideration of Binding Kinetics in the Design of Stapled Peptide Mimics of the Disordered Proteins Eukaryotic Translation Initiation Factor 4E-Binding Protein 1 and Eukaryotic Translation Initiation Factor 4G.
    Gallagher EE; Song JM; Menon A; Mishra LD; Chmiel AF; Garner AL
    J Med Chem; 2019 May; 62(10):4967-4978. PubMed ID: 31033289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.
    Moerke NJ; Aktas H; Chen H; Cantel S; Reibarkh MY; Fahmy A; Gross JD; Degterev A; Yuan J; Chorev M; Halperin JA; Wagner G
    Cell; 2007 Jan; 128(2):257-67. PubMed ID: 17254965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state.
    Ptushkina M; von der Haar T; Karim MM; Hughes JM; McCarthy JE
    EMBO J; 1999 Jul; 18(14):4068-75. PubMed ID: 10406811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancer.
    Papadia A; Schally AV; Halmos G; Varga JL; Seitz S; Buchholz S; Rick F; Zarandi M; Bellyei S; Treszl A; Szalontay L; Lucci JA
    Horm Metab Res; 2011 Oct; 43(11):816-20. PubMed ID: 22009378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
    Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
    Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E.
    Pyronnet S; Imataka H; Gingras AC; Fukunaga R; Hunter T; Sonenberg N
    EMBO J; 1999 Jan; 18(1):270-9. PubMed ID: 9878069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. After fertilization of sea urchin eggs, eIF4G is post-translationally modified and associated with the cap-binding protein eIF4E.
    Oulhen N; Salaün P; Cosson B; Cormier P; Morales J
    J Cell Sci; 2007 Feb; 120(Pt 3):425-34. PubMed ID: 17213333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5'-Cap‒Dependent Translation as a Potent Therapeutic Target for Lethal Human Squamous Cell Carcinoma.
    Srivastava RK; Khan J; Arumugam A; Muzaffar S; Guroji P; Gorbatyuk MS; Elmets CA; Slominski AT; Mukhtar MS; Athar M
    J Invest Dermatol; 2021 Apr; 141(4):742-753.e10. PubMed ID: 32971126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the eIF4E signaling pathway contributes to the progression of gastric cancer, and targeting eIF4E by perifosine inhibits cell growth.
    Liang S; Guo R; Zhang Z; Liu D; Xu H; Xu Z; Wang X; Yang L
    Oncol Rep; 2013 Jun; 29(6):2422-30. PubMed ID: 23588929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
    Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
    Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect of GnRH agonist in epithelial ovarian cancer.
    Kim JH; Park DC; Kim JW; Choi YK; Lew YO; Kim DH; Jung JK; Lim YA; Namkoong SE
    Gynecol Oncol; 1999 Aug; 74(2):170-80. PubMed ID: 10419728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High affinity RNA for mammalian initiation factor 4E interferes with mRNA-cap binding and inhibits translation.
    Mochizuki K; Oguro A; Ohtsu T; Sonenberg N; Nakamura Y
    RNA; 2005 Jan; 11(1):77-89. PubMed ID: 15611299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
    Fister S; Günthert AR; Emons G; Gründker C
    Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.